Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Gains from Investment Securities (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Gains from Investment Securities for 5 consecutive years, with $5000.0 as the latest value for Q4 2020.

  • Quarterly Gains from Investment Securities fell 99.03% to $5000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$256000.0 through Dec 2020, down 149.56% year-over-year, with the annual reading at $12000.0 for FY2025, N/A changed from the prior year.
  • Gains from Investment Securities for Q4 2020 was $5000.0 at Forte Biosciences, up from $166.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $3.5 million in Q4 2018, with the low at -$916000.0 in Q1 2020.
  • Average Gains from Investment Securities over 5 years is $312845.3, with a median of $134325.5 recorded in 2016.
  • Peak annual rise in Gains from Investment Securities hit 1615.01% in 2017, while the deepest fall reached 755.56% in 2017.
  • Over 5 years, Gains from Investment Securities stood at $80000.0 in 2016, then skyrocketed by 792.5% to $714000.0 in 2017, then surged by 386.95% to $3.5 million in 2018, then crashed by 85.14% to $516521.0 in 2019, then tumbled by 99.03% to $5000.0 in 2020.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $5000.0, $166.0, and $821910.0 for Q4 2020, Q3 2020, and Q2 2020 respectively.